Pharmacokinetics and Taste Profile of a Prototype Orally Disintegrating Tablet Formulation
A study to evaluate the pharmacokinetics and taste profile of a prototype orally disintegrating tablet formulation for MK-0663
Peter Dogterom1, Khalid Abd Elaziz1, Ruben de Jong1, Susan J. Lee2 and Paul Fackler2
1QPS Groningen, The Netherlands
2Merck, Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA
2Merck, Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA